SCHEMBL8231278

SCHEMBL8231278

CCCOc1ccc(S(N)(=O)=O)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.88
KDM4E B2RXH2 1/20 0.71
PDE5A O76074 17/20 0.68
PDE2A O00408 1/20 0.67
ABCC4 O15439 1/20 0.67
ABCC5 O15440 1/20 0.67
PDE6D O43924 1/20 0.67
PDE8A O60658 1/20 0.67
PDE9A O76083 1/20 0.67
ABCB11 O95342 1/20 0.67
CYP3A4 P08684 1/20 0.67
HTR1A P08908 1/20 0.67
PDE6A P16499 1/20 0.67
PDE6G P18545 1/20 0.67
PDE4A P27815 1/20 0.67
ADORA2A P29274 1/20 0.67
ADORA1 P30542 1/20 0.67
ADRA1A P35348 1/20 0.67
PDE6B P35913 1/20 0.67
PDE6C P51160 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30233995 1.00 KMT2A (0.88) KMT2AKDM4EPDE5APDE2AABCC4
SCHEMBL1253 0.91 KMT2A (0.73) KMT2AKDM4EPDE5APDE2AABCC4
SCHEMBL31202676 0.91 KMT2A (0.73) KMT2AKDM4EPDE5APDE2AABCC4
SCHEMBL28417921 0.87 PDE5A (0.89) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL7965689 0.86 PDE5A (0.67) KMT2AKDM4EPDE5APDE2AABCC4
SCHEMBL7000981 0.86 KDM4E (0.71) KMT2AKDM4EPDE5APDE2AABCC5
SCHEMBL997 0.86 PDE5A (0.89) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL13990470 0.86 POLB (0.89) KMT2AKDM4EPDE5APDE2APDE9A
SCHEMBL26766365 0.86 KMT2A (0.66) KMT2AKDM4EPDE5APDE2AABCC4
SCHEMBL6628860 0.85 KMT2A (0.85) KMT2AKDM4EPDE5APDE2AABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN disclosed
WO-2007113243-A2 USE OF PDE 5 INHIBITORS FOR THE TREATMENT OF OVERACTIVE BLADDER INVESTIGACIÓN Y CLÍNICA ANDROLÓGICAS S.L. (ES) 2007-10-11 WO disclosed